Biotech/Medical Tech Stock News from Investorideas.com: New #Stocks and Investor Ideas (CSE: $OBRN.C) (CSE: $JKS.C) (Nasdaq: $ACRV) (Nasdaq: $JEWL) (CSE: $PRME.C)

New #Stocks and Investor Ideas (CSE: $OBRN.C) (CSE: $JKS.C) (Nasdaq: $ACRV) (Nasdaq: $JEWL) (CSE: $PRME.C)

#Mining, #Biotech, #LuxuryBrands and #Beverage Stocks Added to Investor Ideas Free Stock Directories

Vancouver, Kelowna, Delta, BC, December 9, 2022 – (Investorideas.com Newswire) Investorideas.com, a global news source and expert investing resource, announces its weekly roundup of stocks to watch in Mining, Biotech, Luxury Brands and Beverages. Today’s stocks have been added to our lists of free stock directories in each sector.

Read this in full at https://www.investorideas.com/news/2022/main/12091Stocks.asp

The newest mining companies both operate within Canada.

The latest biotech and luxury companies are both recent Nasdaq IPOs, while the newest beverage company is involved in the acquisition and management of natural spring water sources in North America.

New Stocks added to the Mining Stocks List:

Oberon Uranium Corp. (CSE:OBRN) is a mineral exploration company with an option to acquire a 100% interest in the past producing Lucky Boy Property located in Arizona, USA. Oberon also has a 100% interest in the Element 92 Property located in Saskatchewan, Canada.

JKS Resources Inc. (CSE:JKS) is in the business of exploration of gold focused mineral properties. JKS holds an option to acquire a 100% interest in the Sowchea Property, subject to a 1% gross over-riding royalty interest in the revenue from the sale of production (the "GORR"). JKS has the right to purchase half of the GORR for $1,000,000 at any time. The Sowchea Property consists of three mineral claims covering approximately 2,280 hectares in the Omineca Mining Division of Central British Columbia.

New Stocks added to the Biotech Stocks List:

Acrivon Therapeutics, Inc. (Nasdaq:ACRV) is a clinical stage biopharmaceutical company developing precision oncology medicines that it matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing Acrivon’s proprietary proteomics-based patient responder identification platform, Acrivon Predictive Precision Proteomics, or AP3. The AP3 platform enables the creation of drug-specific proprietary OncoSignature® companion diagnostics that are used to identify the patients most likely to benefit from Acrivon’s drug candidates. Acrivon is currently advancing its lead candidate, ACR-368, a selective small molecule inhibitor targeting CHK1 and CHK2 in a potentially registrational Phase 2 trial across multiple tumor types. Acrivon’s ACR-368 OncoSignature® test, which has not yet obtained regulatory approval, has been extensively evaluated in preclinical studies, including in two separate, blinded, prospectively-designed studies on pretreatment tumor biopsies collected from past third party Phase 2 trials in patients with ovarian cancer treated with ACR-368. In addition to ACR-368, Acrivon is also developing its internally-discovered preclinical stage pipeline programs targeting critical nodes in the DNA Damage Response, or DDR, including WEE1 and PKMYT1.

New Stocks added to the Luxury Brand Stocks List:

Adamas One Corp. (Nasdaq:JEWL) The Original Lab-Grown Diamond CompanyTM, is a high quality diamond manufacturer based in the United States. We are the originator of the chemical vapor deposition (CVD) process for diamond and a direct company lineage back to Apollo Diamond. Our Lab-Grown Diamonds are identical to the best mined diamonds - optically, physically and chemically. Our technology is eco-friendly with minimal carbon footprint and our diamonds are precisely grown in South Carolina by a team of experienced engineers and technicians. Our customers enjoy beautiful diamonds that are cost effective, eco-friendly and socially conscious. Our investors participate in the fastest growing luxury goods sector with commercially scalable and patent protected technology.

New Stocks added to the Beverage Stocks List:

Prime Drink Group Corp. (CSE:PRME) Formerly Dominion Water Reserves Corp. - primary business is the acquisition and management of natural spring water sources in North America, with an initial focus on the development of the Water Rights located in the Province of Quebec. By combining an acquisition program targeting long-term asset play with a recurring cash flow to reach a critical mass in terms of capacity and geography, and developing, with a focus on prioritizing sustainability and environmental consciousness, groundwater collection, water withdrawal and water pumping for the purpose of selling or distributing spring water, the Company’s goal is securing a leadership role in North America’s spring water market. The Water Rights and Additional Water Rights represent access to over 3 billion liters of spring water per year.

The directories are not meant as recommendations but as a research tool to discover opportunities and trading ideas in a particular sector.

About Investorideas.com - Big Investing Ideas

We publish breaking stock news, stock research, guest posts and create original top rated investing podcasts, plus sector tag articles featuring up and coming companies and industry leaders. Investor Idea’s original branded content includes the Crypto Corner Podcast , Play by Play Sports Podcast , Cannabis News and Stocks on the Move Podcast , Cleantech and Climate Change Podcast, Exploring Mining Podcast , Betting on Gaming Stocks Podcast and the AI Eye Podcast. We also create free investor stock directories for AI and tech, biotech, cannabis, cleantech, crypto, defense, gaming, health and wellness, mining, oil and gas, sports and water.

Public companies within the sectors we cover use our news and content services to tell their story to interested investors. Paid for content is disclosed.

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Learn more about our news, PR and social media, podcast and ticker tag services at Investorideas.com

https://www.investorideas.com/Investors/Services.asp

Learn more about advertising and guest posts

https://www.investorideas.com/Advertise/